Download
s13045-021-01163-6.pdf 3,19MB
WeightNameValue
1000 Titel
  • SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells
1000 Autor/in
  1. Tahk, Siret |
  2. Vick, Binje |
  3. Hiller, Björn |
  4. Schmitt, Saskia |
  5. Marcinek, Anetta |
  6. Perini, Enrico D. |
  7. Leutbecher, Alexandra |
  8. Augsberger, Christian |
  9. Reischer, Anna |
  10. Tast, Benjamin |
  11. Humpe, Andreas |
  12. Jeremias, Irmela |
  13. Subklewe, Marion |
  14. Fenn, Nadja C. |
  15. Hopfner, Karl-Peter |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-09-27
1000 Erschienen in
1000 Quellenangabe
  • 14(1):155
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s13045-021-01163-6 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477557/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Acute myeloid leukaemia (AML) stem cells (LSCs) cause disease relapse. The CD47 'don't eat me signal' is upregulated on LSCs and contributes to immune evasion by inhibiting phagocytosis through interacting with myeloid-specific signal regulatory protein alpha (SIRPα). Activation of macrophages by blocking CD47 has been successful, but the ubiquitous expression of CD47 on healthy cells poses potential limitations for such therapies. In contrast, CD123 is a well-known LSC-specific surface marker utilized as a therapeutic target. Here, we report the development of SIRPα-αCD123 fusion antibodies that localize the disruption of CD47/SIRPα signalling to AML while specifically enhancing LSC clearance.!##!Methods!#!SIRPα-αCD123 antibodies were generated by fusing the extracellular domain of SIRPα to an αCD123 antibody. The binding properties of the antibodies were analysed by flow cytometry and surface plasmon resonance. The functional characteristics of the fusion antibodies were determined by antibody-dependent cellular phagocytosis and antibody-dependent cellular cytotoxicity assays using primary AML patient cells. Finally, an in vivo engraftment assay was utilized to assess LSC targeting.!##!Results!#!SIRPα-αCD123 fusion antibodies exhibited increased binding and preferential targeting of CD123!##!Conclusions!#!SIRPα-αCD123 antibodies combine local CD47 blockade with specific LSC targeting in a single molecule, minimize the risk of targeting healthy cells and efficiently eliminate AML LSCs. These results validate SIRPα-αCD123 antibodies as promising therapeutic interventions for AML.
1000 Sacherschließung
lokal Female [MeSH]
lokal Cell Line, Tumor [MeSH]
lokal CD123
lokal Acute myeloid leukaemia
lokal Aged, 80 and over [MeSH]
lokal Antigens, Differentiation/immunology [MeSH]
lokal Aged [MeSH]
lokal Neoplastic Stem Cells/drug effects [MeSH]
lokal Adult [MeSH]
lokal Neoplastic Stem Cells/immunology [MeSH]
lokal Humans [MeSH]
lokal CD47 Antigen/immunology [MeSH]
lokal Interleukin-3 Receptor alpha Subunit/immunology [MeSH]
lokal Leukemia, Myeloid, Acute/immunology [MeSH]
lokal Middle Aged [MeSH]
lokal Leukemic stem cells
lokal Male [MeSH]
lokal Antineoplastic Agents, Immunological/therapeutic use [MeSH]
lokal Phagocytosis
lokal Research
lokal Immunotherapy
lokal Leukemia, Myeloid, Acute/drug therapy [MeSH]
lokal Receptors, Immunologic/immunology [MeSH]
lokal CD47
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/VGFoaywgU2lyZXQ=|https://frl.publisso.de/adhoc/uri/VmljaywgQmluamU=|https://frl.publisso.de/adhoc/uri/SGlsbGVyLCBCasO2cm4=|https://frl.publisso.de/adhoc/uri/U2NobWl0dCwgU2Fza2lh|https://frl.publisso.de/adhoc/uri/TWFyY2luZWssIEFuZXR0YQ==|https://frl.publisso.de/adhoc/uri/UGVyaW5pLCBFbnJpY28gRC4=|https://frl.publisso.de/adhoc/uri/TGV1dGJlY2hlciwgQWxleGFuZHJh|https://frl.publisso.de/adhoc/uri/QXVnc2JlcmdlciwgQ2hyaXN0aWFu|https://frl.publisso.de/adhoc/uri/UmVpc2NoZXIsIEFubmE=|https://frl.publisso.de/adhoc/uri/VGFzdCwgQmVuamFtaW4=|https://frl.publisso.de/adhoc/uri/SHVtcGUsIEFuZHJlYXM=|https://frl.publisso.de/adhoc/uri/SmVyZW1pYXMsIElybWVsYQ==|https://frl.publisso.de/adhoc/uri/U3Via2xld2UsIE1hcmlvbg==|https://frl.publisso.de/adhoc/uri/RmVubiwgTmFkamEgQy4=|https://orcid.org/0000-0002-4528-8357
1000 Hinweis
  • DeepGreen-ID: 93706c8926d244d797a3e7516d7a7c00 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6463837.rdf
1000 Erstellt am 2023-11-15T21:50:46.423+0100
1000 Erstellt von 322
1000 beschreibt frl:6463837
1000 Zuletzt bearbeitet 2023-11-30T22:26:54.019+0100
1000 Objekt bearb. Thu Nov 30 22:26:54 CET 2023
1000 Vgl. frl:6463837
1000 Oai Id
  1. oai:frl.publisso.de:frl:6463837 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source